Ovid Therapeutics (OVID) Competitors

Ovid Therapeutics (NASDAQ:OVID) and TherapeuticsMD (NASDAQ:TXMD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

Does the MarketBeat Community believe in OVID or TXMD?

TherapeuticsMD received 36 more outperform votes than Ovid Therapeutics when rated by MarketBeat users. However, 70.56% of users gave Ovid Therapeutics an outperform vote while only 61.27% of users gave TherapeuticsMD an outperform vote.

Company	Underperform	Outperform
Ovid Therapeutics	Outperform Votes 350 70.56%	Underperform Votes 146 29.44%
TherapeuticsMD	Outperform Votes 386 61.27%	Underperform Votes 244 38.73%

Does the media favor OVID or TXMD?

In the previous week, Ovid Therapeutics had 8 more articles in the media than TherapeuticsMD. MarketBeat recorded 11 mentions for Ovid Therapeutics and 3 mentions for TherapeuticsMD. TherapeuticsMD's average media sentiment score of 0.72 beat Ovid Therapeutics' score of 0.58 indicating that TherapeuticsMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ovid Therapeutics	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
TherapeuticsMD	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer OVID or TXMD?

Ovid Therapeutics presently has a consensus price target of $4.70, suggesting a potential upside of 343.40%. Given Ovid Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Ovid Therapeutics is more favorable than TherapeuticsMD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ovid Therapeutics	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
TherapeuticsMD	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more volatility and risk, OVID or TXMD?

Ovid Therapeutics has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Comparatively, TherapeuticsMD has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

Do institutionals and insiders believe in OVID or TXMD?

72.2% of Ovid Therapeutics shares are owned by institutional investors. Comparatively, 30.7% of TherapeuticsMD shares are owned by institutional investors. 13.3% of Ovid Therapeutics shares are owned by company insiders. Comparatively, 1.2% of TherapeuticsMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is OVID or TXMD more profitable?

TherapeuticsMD has a net margin of 0.00% compared to Ovid Therapeutics' net margin of -10,691.14%. TherapeuticsMD's return on equity of -21.15% beat Ovid Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ovid Therapeutics	-10,691.14%	-53.62%	-37.76%
TherapeuticsMD	N/A	-21.15%	-13.08%

Which has higher valuation and earnings, OVID or TXMD?

TherapeuticsMD has higher revenue and earnings than Ovid Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ovid Therapeutics	$390K	192.81	-$52.34M	-$0.73	-1.45
TherapeuticsMD	$1.30M	16.23	-$10.28M	N/A	N/A

Summary

Ovid Therapeutics and TherapeuticsMD tied by winning 8 of the 16 factors compared between the two stocks.